Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms
- PMID: 27979797
- PMCID: PMC7959985
- DOI: 10.3174/ajnr.A5024
Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms
Abstract
Background and purpose: For patients with cerebral vasospasm refractory to medical and hemodynamic therapies, endovascular therapies often remain the last resort. Data from studies in large cohorts on the efficacy and safety of multiple immediate endovascular interventions are sparse. Our aim was to assess the feasibility and safety of multiple repeat instant endovascular interventions in patients with cerebral vasospasm refractory to medical, hemodynamic, and initial endovascular interventions.
Materials and methods: This was a single-center retrospective study of prospectively collected data on patients with cerebral vasospasm refractory to therapies requiring ≥3 endovascular interventions during the course of treatment following aneurysmal subarachnoid hemorrhage. The primary end point was functional outcome at last follow-up (mRS ≤2). The secondary end point was angiographic response to endovascular therapies and the appearance of cerebral infarctions.
Results: During a 4-year period, 365 patients with aneurysmal subarachnoid hemorrhage were treated at our institution. Thirty-one (8.5%) met the inclusion criteria. In 52 (14%) patients, ≤2 endovascular interventions were performed as rescue therapy for refractory cerebral vasospasm. At last follow-up, a good outcome was noted in 18 (58%) patients with ≥3 interventions compared with 31 (61%) of those with ≤2 interventions (P = .82). The initial Hunt and Hess score of ≤2 was a significant independent predictor of good outcome (OR, 4.7; 95% CI, 1.2-18.5; P = .03), whereas infarcts in eloquent brain areas were significantly associated with a poor outcome (mRS 3-6; OR, 13.5; 95% CI, 2.3-81.2; P = .004).
Conclusions: Repeat instant endovascular intervention is an aggressive but feasible last resort treatment strategy with a favorable outcome in two-thirds of patients with refractory cerebral vasospasm and in whom endovascular treatment has already been initiated.
© 2017 by American Journal of Neuroradiology.
Conflict of interest statement
The authors declare no conflict of interest. This study was approved by the Ethics Committee of the Canton of Bern, Switzerland (Kantonale Ethikkommission Bern, KEK, 177/14).
Figures

Comment in
-
Endovascular Rescue Therapy for Refractory Vasospasm: When and How?AJNR Am J Neuroradiol. 2017 Mar;38(3):568-569. doi: 10.3174/ajnr.A5082. Epub 2017 Jan 12. AJNR Am J Neuroradiol. 2017. PMID: 28082262 Free PMC article. No abstract available.
Similar articles
-
Low neurologic intensive care unit hemoglobin as a predictor for intra-arterial vasospasm therapy and poor discharge modified Rankin Scale in aneurysmal subarachnoid haemorrhage-induced cerebral vasospasm.J Neurointerv Surg. 2015 Jun;7(6):438-42. doi: 10.1136/neurintsurg-2014-011164. Epub 2014 May 9. J Neurointerv Surg. 2015. PMID: 24814068
-
Endovascular Rescue Therapies for Refractory Vasospasm After Subarachnoid Hemorrhage: A Prospective Evaluation Study Using Multimodal, Continuous Event Neuromonitoring.Neurosurgery. 2017 Jun 1;80(6):942-949. doi: 10.1093/neuros/nyw132. Neurosurgery. 2017. PMID: 28201539
-
Efficacy of endovascular treatment and feasibility of stent-assisted coiling in the presence of severe and symptomatic vasospasm.J Neurointerv Surg. 2017 Nov;9(11):1075-1080. doi: 10.1136/neurintsurg-2016-012734. Epub 2016 Nov 3. J Neurointerv Surg. 2017. PMID: 27811177
-
Safety and outcomes of simultaneous vasospasm and endovascular aneurysm treatment (SVAT) in subarachnoid hemorrhage.J Neurointerv Surg. 2017 May;9(5):482-485. doi: 10.1136/neurintsurg-2016-012714. Epub 2016 Oct 27. J Neurointerv Surg. 2017. PMID: 27789791 Review.
-
A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.World Neurosurg. 2019 Jun;126:513-527. doi: 10.1016/j.wneu.2019.03.083. Epub 2019 Mar 18. World Neurosurg. 2019. PMID: 30898740 Review.
Cited by
-
Outcome analysis for patients with subarachnoid hemorrhage and vasospasm including endovascular treatment.Neurol Res Pract. 2023 Nov 2;5(1):57. doi: 10.1186/s42466-023-00283-3. Neurol Res Pract. 2023. PMID: 37915071 Free PMC article.
-
Reliability of the Diagnosis of Cerebral Vasospasm Using Catheter Cerebral Angiography: A Systematic Review and Inter- and Intraobserver Study.AJNR Am J Neuroradiol. 2021 Mar;42(3):501-507. doi: 10.3174/ajnr.A7021. Epub 2021 Jan 28. AJNR Am J Neuroradiol. 2021. PMID: 33509923 Free PMC article.
-
The Impact of Endovascular Rescue Therapy on the Clinical and Radiological Outcome After Aneurysmal Subarachnoid Hemorrhage: A Safe and Effective Treatment Option for Hemodynamically Relevant Vasospasm?Front Neurol. 2022 May 9;13:838456. doi: 10.3389/fneur.2022.838456. eCollection 2022. Front Neurol. 2022. PMID: 35614929 Free PMC article.
-
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Delayed Cerebral Ischemia.Front Neurol. 2022 Feb 18;13:817072. doi: 10.3389/fneur.2022.817072. eCollection 2022. Front Neurol. 2022. PMID: 35250821 Free PMC article.
-
The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.Brain Sci. 2020 Mar 7;10(3):153. doi: 10.3390/brainsci10030153. Brain Sci. 2020. PMID: 32156050 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous